Jeremy P Presland (Jeremy Presland)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2021
Publications (10 Years): 2

Top Topics

Transcription Factor

Dendritic Cells

Rheumatoid Arthritis

Top Venues

Science (New York, N.Y.)

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Samanthi A Perera, Johnny E Kopinja, Yanhong Ma, Eric S Muise, Jason Laskey, Kalyan Chakravarthy, Yiping Chen, Long Cui, Jeremy P Presland, Manjiri Sathe, Sarah Javaid, Ellen C Minnihan, Heidi M Ferguson, Jennifer Piesvaux, Bo-Sheng Pan, Shuxia Zhao, Sharad K Sharma, Hyun Chong Woo, Vincenzo Pucci, Ian Knemeyer, Saso Cemerski, Jared Cumming, B Wesley Trotter, Archie Tse, Anuradha Khilnani, Sheila Ranganath, Brian J Long, David Jonathan Bennett, George H Addona
STimulator of INterferon Genes Agonism Accelerates Anti-tumor Activity in Poorly Immunogenic Tumors. Molecular cancer therapeutics (2021)
Bo-Sheng Pan, Samanthi A Perera, Jennifer A Piesvaux, Jeremy P Presland, Gottfried K Schroeder, Jared N Cumming, Benjamin Wesley Trotter, Michael D Altman, Alexei V Buevich, Brandon Cash, Saso Cemerski, Wonsuk Chang, Yiping Chen, Peter J Dandliker, Guo Feng, Andrew M Haidle, Timothy Henderson, James Jewell, Ilona Kariv, Ian Knemeyer, Johnny E Kopinja, Brian M Lacey, Jason Laskey, Charles A Lesburg, Rui Liang, Brian J Long, Min Lu, Yanhong Ma, Ellen C Minnihan, Greg O'Donnell, Ryan Otte, Laura Price, Larissa Rakhilina, Berengere Sauvagnat, Sharad K Sharma, Sriram Tyagarajan, Hyun Woo, Daniel F Wyss, Serena Xu, David Jonathan Bennett, George H Addona
An orally available non-nucleotide STING agonist with antitumor activity. Science (New York, N.Y.) 369 (6506) (2020)